Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications

introduced

The Drug Enforcement Administration (DEA) jointly with the Department of Health and Human Services (HHS) is issuing a fourth extension of telemedicine flexibilities for the prescribing of controlled medications through December 31, 2026.

No lobbying positions or financial data recorded for this regulation yet.

Public comment data and advocacy positions are added as they become available.